成立于1997年,較早布局中醫藥全產業,以中藥飲片為核心,以智慧藥房為抓手,打造大健康+大平臺+大數據+大服務體系
康美藥業(ye)(ye)股(gu)份有限公司(600518)成立于(yu)1997年,于(yu)2001年在上(shang)(shang)(shang)交所(suo)上(shang)(shang)(shang)市。公司秉(bing)承(cheng)“心懷蒼生、大(da)(da)愛(ai)無疆”的核心價值觀和“用(yong)愛(ai)感(gan)動世界、用(yong)心經營健康”的經營理(li)念,在國家(jia)(jia)振興中(zhong)(zhong)醫藥事業(ye)(ye)戰(zhan)略指引(yin)下,布局中(zhong)(zhong)醫藥全(quan)產(chan)業(ye)(ye)鏈,以中(zhong)(zhong)藥飲(yin)片為核心,以智慧(hui)藥房為抓手,打造“大(da)(da)健康+大(da)(da)平(ping)臺+大(da)(da)數據+大(da)(da)服務(wu)”體系(xi),成為中(zhong)(zhong)醫藥全(quan)產(chan)業(ye)(ye)鏈精準服務(wu)型“智慧(hui)+”大(da)(da)健康產(chan)業(ye)(ye)上(shang)(shang)(shang)市企業(ye)(ye)、國家(jia)(jia)高新技術企業(ye)(ye)。
康美(mei)(mei)(mei)藥(yao)(yao)(yao)(yao)(yao)(yao)業(ye)(ye)(ye)上(shang)(shang)至藥(yao)(yao)(yao)(yao)(yao)(yao)材(cai)種(zhong)植(zhi)、藥(yao)(yao)(yao)(yao)(yao)(yao)材(cai)交(jiao)(jiao)易(yi)(yi)(yi),下至生產(chan)(chan)(chan)(chan)(chan)開發、終端銷售,已(yi)(yi)基本貫穿中(zhong)(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)產(chan)(chan)(chan)(chan)(chan)業(ye)(ye)(ye)鏈的(de)(de)上(shang)(shang)、中(zhong)(zhong)(zhong)(zhong)(zhong)、下游產(chan)(chan)(chan)(chan)(chan)業(ye)(ye)(ye),業(ye)(ye)(ye)務(wu)滲透(tou)中(zhong)(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)全(quan)產(chan)(chan)(chan)(chan)(chan)業(ye)(ye)(ye)鏈的(de)(de)各個關(guan)鍵(jian)環節(jie),有效地(di)整合全(quan)產(chan)(chan)(chan)(chan)(chan)業(ye)(ye)(ye)鏈資源。公(gong)司先后在(zai)全(quan)國(guo)(guo)(guo)(guo)(guo)(guo)(guo)各地(di)投資建(jian)立140多(duo)家(jia)涵蓋藥(yao)(yao)(yao)(yao)(yao)(yao)材(cai)種(zhong)植(zhi)、中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)材(cai)交(jiao)(jiao)易(yi)(yi)(yi)市場、現代物流中(zhong)(zhong)(zhong)(zhong)(zhong)心和(he)(he)產(chan)(chan)(chan)(chan)(chan)業(ye)(ye)(ye)基地(di)等(deng)業(ye)(ye)(ye)務(wu)的(de)(de)企業(ye)(ye)(ye),管(guan)理的(de)(de)交(jiao)(jiao)易(yi)(yi)(yi)市場交(jiao)(jiao)易(yi)(yi)(yi)規模(mo)(mo)占全(quan)國(guo)(guo)(guo)(guo)(guo)(guo)(guo)的(de)(de)60%以上(shang)(shang),做(zuo)出了多(duo)個方面的(de)(de)國(guo)(guo)(guo)(guo)(guo)(guo)(guo)家(jia)標(biao)(biao)(biao)準(zhun)(zhun):制(zhi)(zhi)定中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)飲片國(guo)(guo)(guo)(guo)(guo)(guo)(guo)家(jia)標(biao)(biao)(biao)準(zhun)(zhun)以及(ji)生產(chan)(chan)(chan)(chan)(chan)管(guan)理GMP、小包裝、色標(biao)(biao)(biao)管(guan)理、炮(pao)制(zhi)(zhi)等(deng)國(guo)(guo)(guo)(guo)(guo)(guo)(guo)家(jia)標(biao)(biao)(biao)準(zhun)(zhun)。參與國(guo)(guo)(guo)(guo)(guo)(guo)(guo)家(jia)商(shang)務(wu)部(bu)中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)材(cai)等(deng)級分類(lei)標(biao)(biao)(biao)準(zhun)(zhun)制(zhi)(zhi)訂(ding)。承擔(dan)編(bian)制(zhi)(zhi)和(he)(he)運營(ying)國(guo)(guo)(guo)(guo)(guo)(guo)(guo)家(jia)發改(gai)委批準(zhun)(zhun)、授權發布的(de)(de)全(quan)國(guo)(guo)(guo)(guo)(guo)(guo)(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)材(cai)價格指數(shu)——康美(mei)(mei)(mei)·中(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)(guo)(guo)(guo)(guo)(guo)(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)材(cai)價格指數(shu)。推(tui)出“實(shi)體(ti)與虛擬(ni)市場相結(jie)合”的(de)(de)中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)材(cai)大(da)宗現貨交(jiao)(jiao)易(yi)(yi)(yi)平(ping)臺,開創中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)材(cai)交(jiao)(jiao)易(yi)(yi)(yi)新(xin)模(mo)(mo)式(shi)。承擔(dan)編(bian)制(zhi)(zhi)700多(duo)項(xiang)(xiang)中(zhong)(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)編(bian)碼的(de)(de)國(guo)(guo)(guo)(guo)(guo)(guo)(guo)家(jia)標(biao)(biao)(biao)準(zhun)(zhun),助力實(shi)施統一(yi)的(de)(de)中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)、中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)方劑、中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)供應鏈編(bian)碼體(ti)系、成為國(guo)(guo)(guo)(guo)(guo)(guo)(guo)家(jia)信息化醫(yi)(yi)療機(ji)構服務(wu)平(ping)臺試點單(dan)位,康美(mei)(mei)(mei)智(zhi)慧藥(yao)(yao)(yao)(yao)(yao)(yao)房(fang)被列為國(guo)(guo)(guo)(guo)(guo)(guo)(guo)家(jia)中(zhong)(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)服務(wu)標(biao)(biao)(biao)準(zhun)(zhun)化研究基地(di),打(da)造了互聯網時代的(de)(de)就醫(yi)(yi)用藥(yao)(yao)(yao)(yao)(yao)(yao)新(xin)模(mo)(mo)式(shi)。是承擔(dan)藥(yao)(yao)(yao)(yao)(yao)(yao)典(dian)會動物藥(yao)(yao)(yao)(yao)(yao)(yao)中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)飲片炮(pao)制(zhi)(zhi)規范項(xiang)(xiang)目企業(ye)(ye)(ye),獲(huo)批國(guo)(guo)(guo)(guo)(guo)(guo)(guo)家(jia)民(min)營(ying)網絡醫(yi)(yi)院(yuan)(yuan)(yuan)(yuan)資質。組建(jian)了由6位中(zhong)(zhong)(zhong)(zhong)(zhong)科院(yuan)(yuan)(yuan)(yuan)、工程院(yuan)(yuan)(yuan)(yuan)院(yuan)(yuan)(yuan)(yuan)士及(ji)眾多(duo)國(guo)(guo)(guo)(guo)(guo)(guo)(guo)醫(yi)(yi)大(da)師組成的(de)(de)專家(jia)委員會,在(zai)廣(guang)州和(he)(he)北京(jing)設(she)立康美(mei)(mei)(mei)藥(yao)(yao)(yao)(yao)(yao)(yao)物研究院(yuan)(yuan)(yuan)(yuan),擁有“國(guo)(guo)(guo)(guo)(guo)(guo)(guo)家(jia)企業(ye)(ye)(ye)技(ji)術中(zhong)(zhong)(zhong)(zhong)(zhong)心”等(deng)20多(duo)個國(guo)(guo)(guo)(guo)(guo)(guo)(guo)家(jia)及(ji)省部(bu)級研發平(ping)臺和(he)(he)14個自主(zhu)研發平(ping)臺,已(yi)(yi)開展(zhan)中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)國(guo)(guo)(guo)(guo)(guo)(guo)(guo)際化、中(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)標(biao)(biao)(biao)準(zhun)(zhun)化等(deng)國(guo)(guo)(guo)(guo)(guo)(guo)(guo)家(jia)及(ji)省部(bu)級重(zhong)大(da)項(xiang)(xiang)目近百(bai)個,主(zhu)持和(he)(he)參加制(zhi)(zhi)定國(guo)(guo)(guo)(guo)(guo)(guo)(guo)家(jia)、行業(ye)(ye)(ye)標(biao)(biao)(biao)準(zhun)(zhun)數(shu)十項(xiang)(xiang),獲(huo)批國(guo)(guo)(guo)(guo)(guo)(guo)(guo)家(jia)或國(guo)(guo)(guo)(guo)(guo)(guo)(guo)際組織認證的(de)(de)實(shi)驗(yan)室3個,獲(huo)得省級及(ji)以上(shang)(shang)科技(ji)獎(jiang)勵15項(xiang)(xiang)。擁有發明(ming)專利、實(shi)用新(xin)型專利、外(wai)觀設(she)計專利、軟件著作權等(deng)知(zhi)識產(chan)(chan)(chan)(chan)(chan)權達620余(yu)項(xiang)(xiang),是國(guo)(guo)(guo)(guo)(guo)(guo)(guo)家(jia)技(ji)術創新(xin)示范企業(ye)(ye)(ye)和(he)(he)國(guo)(guo)(guo)(guo)(guo)(guo)(guo)家(jia)智(zhi)能制(zhi)(zhi)造試點示范企業(ye)(ye)(ye)、國(guo)(guo)(guo)(guo)(guo)(guo)(guo)家(jia)知(zhi)識產(chan)(chan)(chan)(chan)(chan)權優勢(shi)企業(ye)(ye)(ye)。
公(gong)司在全國建立了(le)17個中藥(yao)飲片和(he)醫(yi)(yi)(yi)藥(yao)現代化生產(chan)基(ji)地,與超過2000家醫(yi)(yi)(yi)療機構、20萬家藥(yao)店建立了(le)合作關系,年門診總量達到2.5億人次以(yi)上,投資(zi)管理康(kang)美醫(yi)(yi)(yi)院、康(kang)美梅河(he)口中心(xin)醫(yi)(yi)(yi)院、康(kang)美開原市(shi)中心(xin)醫(yi)(yi)(yi)院、康(kang)美通城人民醫(yi)(yi)(yi)院、康(kang)美柳河(he)中心(xin)醫(yi)(yi)(yi)院等多(duo)家公(gong)立醫(yi)(yi)(yi)院,在100多(duo)家公(gong)立醫(yi)(yi)(yi)院開展醫(yi)(yi)(yi)藥(yao)物流(liu)延伸配(pei)送(song)服務(wu)。
公(gong)司以(yi)國家(jia)中(zhong)(zhong)醫(yi)藥(yao)(yao)管理局信(xin)息(xi)化醫(yi)療(liao)服務(wu)平臺試(shi)點單位為契機(ji),在中(zhong)(zhong)醫(yi)藥(yao)(yao)行業(ye)把互聯網深度布局全(quan)產(chan)業(ye)鏈中(zhong)(zhong),以(yi)中(zhong)(zhong)藥(yao)(yao)飲片為核心,以(yi)智(zhi)慧(hui)藥(yao)(yao)房(fang)(fang)為抓(zhua)手,圍繞“大健康+大平臺+大數據+大服務(wu)”體系(xi),以(yi)全(quan)產(chan)業(ye)鏈資源優勢,積(ji)極探索(suo)中(zhong)(zhong)醫(yi)藥(yao)(yao)工業(ye)智(zhi)能制造(zao)4.0,打造(zao)“智(zhi)慧(hui)藥(yao)(yao)房(fang)(fang)”模(mo)式,國務(wu)院辦公(gong)廳(ting)、國家(jia)衛健委(wei)、國家(jia)中(zhong)(zhong)醫(yi)藥(yao)(yao)管理局先后(hou)發文,明確“鼓勵有條件的醫(yi)療(liao)機(ji)構推進‘智(zhi)慧(hui)藥(yao)(yao)房(fang)(fang)’建設,實(shi)現處方(fang)系(xi)統(tong)與藥(yao)(yao)房(fang)(fang)配方(fang)系(xi)統(tong)無縫對接。”“智(zhi)慧(hui)藥(yao)(yao)房(fang)(fang)”模(mo)式上升(sheng)為行業(ye)標(biao)準,為患者提供了(le)“一站式”藥(yao)(yao)事(shi)服務(wu),實(shi)現了(le)“讓信(xin)息(xi)多跑路,讓群眾(zhong)少(shao)跑腿”。
康(kang)美藥業(ye)(ye)將以“經營(ying)有(you)界、突出主業(ye)(ye)”為指導思想(xiang),圍繞“聚焦核心(xin)業(ye)(ye)務(wu)(wu)、提高核心(xin)競爭力”的(de)工(gong)作方針,明確(que)以中藥飲片及(ji)其制品為核心(xin)業(ye)(ye)務(wu)(wu),通過有(you)機整合(he)公司的(de)產(chan)業(ye)(ye)布局優勢(shi)、線(xian)上線(xian)下互相強化的(de)采購(gou)優勢(shi)、研發(fa)制成與質管優勢(shi)、營(ying)銷服務(wu)(wu)優勢(shi),成為具備中醫藥全產(chan)業(ye)(ye)鏈動態(tai)整合(he)和(he)規范(fan)經營(ying)能力的(de)標桿企業(ye)(ye)。